Erratum: Radioembolization for the treatment of liver tumors: General principles: (American Journal of Clinical Oncology: Cancer Clinical Trials (2012) 35 (91-99) doi: 10.1097/COC.0b013e3181f47583);Radioembolization for the treatment of liver tumors: General principles

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 35, Issue 1, 2012, Pages 91-99

  Kennedy, Andrew ^a,b,c   Coldwell, Douglas ^d   Sangro, Bruno ^f,g   Wasan, Harpreet ^h   Salem, Riad ^e  

^a Wake Radiology Oncology   (United States)

^b North Carolina State University   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF LOUISVILLE HOSPITAL   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f UNIVERSITY CLINIC OF NAVARRA   (Spain)

^g UNIVERSITY OF NAVARRA   (Spain)

^h HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

dosimetry; hepatic; metastases; SIRT; yttrium 90

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; HISTAMINE H2 RECEPTOR ANTAGONIST; MACROSALB TC 99M; MICROSPHERE; PROTON PUMP INHIBITOR; SOMATOSTATIN DERIVATIVE; TUMOR MARKER; YTTRIUM 90;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANALGESIA; ANTIEMETIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; ARTIFICIAL EMBOLISM; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BASAL METABOLIC RATE; BLOOD CELL COUNT; BLOOD CLOTTING; BODY SURFACE; CARCINOID SYNDROME; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONVENTIONAL EMBOLIZATION; DIGESTIVE SYSTEM INFLAMMATION; DOSIMETRY; FEVER; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; INFECTION; LETHARGY; LIVER ANGIOGRAPHY; LIVER DISEASE; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER TUMOR; MALAISE; MICRODOSIMETRY; NAUSEA; NUCLEAR MAGNETIC RESONANCE; OUTCOME ASSESSMENT; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; QUALITY OF LIFE; RADIATION DOSE; RADIATION INJURY; RADIOEMBOLIZATION; TREATMENT PLANNING; TREATMENT RESPONSE; ULCER;

EID: 84856265937     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e318295af1d     Document Type: Erratum

References (26)

1. 90Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys. 2004; 60:1552-1563. (Pubitemid 39601873)
2. Burton M, Gray B, Kelleher D, et al. Selective internal radiation therapy: validation of intraoperative dosimetry. Radiol. 1990;175:253-255. (Pubitemid 20108575)
3. Gray B, Burton M, Kelleher D, et al. Selective internal radiation (SIR) therapy for treatment of liver metastases: measurement of response rate. J Surg Oncol. 1989;42:192-196. (Pubitemid 19285063)
4. Burton M, Gray B, Klemp P, et al. Selective internal radiation therapy: distribution of radiation in the liver. Eur J Cancer Clin Oncol. 1989;25:1487-1491. (Pubitemid 19247458)
5. Ackerman NB, Lien WM, Kondi ES, et al. The blood supply of experimental liver metastases. I: the distribution of hepatic artery and portal vein blood to "small" and "large" tumors. Surgery. 1970;66:1067-1072.
6. Archer SG, Gray BN. Vascularization of small liver metastases. Br J Surg. 1989;76:545-548. (Pubitemid 19155723)
7. Kennedy A, Nag S, Salem R, et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the Radioembolization Brachytherapy Oncology Consortium (REBOC). Int J Radiat Oncol Biol Phys. 2007;68:13-23. (Pubitemid 46589861)
8. Fox RA, Klemp PF, Egan G, et al. Dose distribution following selective internal radiation therapy. Int J Radiat Oncol Biol Phys. 1991;21:463-467.
9. Toohey RE, Stabin MG, Watson EE. The AAPM/RSNA physics tutorial for residents: internal radiation dosimetry: principles and applications. Radiographics. 2000;20:533-546; quiz 531-532.
10. Sirtex Medical Limited. SIR-Spheres User's Manual. 2002;38-42.
11. Sirtex Medical Limited. SIR-Spheres Package Insert. 2004.
12. 90Y- microspheres for unresectable hepatic tumors. Int J Radiat Oncol Biol Phys. 2009;74:1494-1500.
13. 90Y-microsphere radioembolization. Presented as a poster at 2008 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2007; Abstract 191.
14. Young JY, Rhee TK, Atassi B, et al. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma. J Vasc Interv Radiol. 2007;18:1375-1382. (Pubitemid 47628904)
15. Erturk SM, Ichikawa T, Fujii H, et al. PET imaging for evaluation of metastatic colorectal cancer of the liver. Eur J Radiol. 2006;58:229-235.
16. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer. 1981;47:207-214. (Pubitemid 11167383)
17. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205-216.
18. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228-247.
19. Miller FH, Keppke AL, Reddy D, et al. Response of liver metastases after treatment with yttrium-90 microspheres: role of size, necrosis, and PET. AJR Am J Roentgenol. 2007;188: 776-783.
20. 90Y. January 1998; www.nndc.bnl.gov/useroutput/90y-mird.html
21. Van Hazel G, Blackwell A, Anderson J, et al. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol. 2004;88:78-85. (Pubitemid 39536508)
22. Sharma R, van Hazel G, Morgan B, et al. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol. 2007;25:1099-1106. (Pubitemid 46596762)
23. 90Yttrium resin microspheres alone in unresectable, heavily pre-treated colorectal liver metastases results of a phase II trial Presented as a poster at 2008 American Society of Clinical Oncology (ASCO) Annual Meeting. J Clin Oncol. 2008;26(May 20 Supplement); Abstract 4078.
24. Van den Eynde M, Hendlisz A, Peeters M, et al. Prospective randomized study comparing intra-arterial injection of yttrium-90 resin microspheres with protracted IV 5FU continuous infusion versus IV 5FU continuous infusion alone for patients with liverlimited metastatic colorectal cancer refractory to standard chemotherapy. Presented as a poster at 2009 American Society of Clinical Oncology (ASCO) Annual Meeting. J Clin Oncol. 2009;27(suppl 7s); Abstract 4096.
25. Seidensticker M, Rühl R, Kraus P, et al. Radioembolization with yttrium-90 resin microspheres as a salvage treatment for refractory liver-dominant colorectal metastases: a matched-pair analysis. Presented as a poster at ECCO 15/34th ESMO. Eur J Cancer Suppl. 2009;7(2):343; Abstract 6071.
26. 90Y-microsphere brachytherapy for unresectable colorectal metastases: modern USA experience. Int J Radiat Oncol Biol Phys. 2006;65:412-425.